{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T08:03:48Z","timestamp":1780473828413,"version":"3.54.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T00:00:00Z","timestamp":1697673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T00:00:00Z","timestamp":1697673600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1007\/s10072-023-07125-9","type":"journal-article","created":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T03:27:52Z","timestamp":1697686072000},"page":"1173-1183","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Risk of central nervous system demyelinating attack or optic neuritis recurrence after pediatric optic neuritis in Korea"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9553-2231","authenticated-orcid":false,"given":"Yeji","family":"Moon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7907-5635","authenticated-orcid":false,"given":"Kyung-Ah","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8607-6625","authenticated-orcid":false,"given":"Jinu","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0837-2864","authenticated-orcid":false,"given":"Jeong-Min","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7944-6990","authenticated-orcid":false,"given":"Seong-Joon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8972-4790","authenticated-orcid":false,"given":"Sueng-Han","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4210-7650","authenticated-orcid":false,"given":"Byung Joo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9514-7440","authenticated-orcid":false,"given":"Min Chae","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-3293-5665","authenticated-orcid":false,"given":"Yong Hyu","family":"Goh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8509-4135","authenticated-orcid":false,"given":"Byung Chan","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee Kyung","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4742-4903","authenticated-orcid":false,"given":"Jae Ho","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,19]]},"reference":[{"key":"7125_CR1","first-page":"727","volume":"65","author":"Optic Neuritis Study G","year":"2008","unstructured":"Optic Neuritis Study G (2008) Multiple sclerosis risk after optic neuritis: final optic neuritis treatment trial follow-up. Arch Neurol 65:727\u2013732","journal-title":"Arch Neurol"},{"key":"7125_CR2","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1212\/WNL.49.5.1413","volume":"49","author":"CF Lucchinetti","year":"1997","unstructured":"Lucchinetti CF, Kiers L, O\u2019Duffy A, Gomez MR, Cross S, Leavitt JA, O\u2019Brien P, Rodriguez M (1997) Risk factors for developing multiple sclerosis after childhood optic neuritis. Neurology 49:1413\u20131418","journal-title":"Neurology"},{"key":"7125_CR3","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1212\/01.wnl.0000224757.69746.fb","volume":"67","author":"M Wilejto","year":"2006","unstructured":"Wilejto M, Shroff M, Buncic JR, Kennedy J, Goia C, Banwell B (2006) The clinical features, MRI findings, and outcome of optic neuritis in children. Neurology 67:258\u2013262","journal-title":"Neurology"},{"key":"7125_CR4","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.ejpn.2008.09.003","volume":"13","author":"G Cakmakli","year":"2009","unstructured":"Cakmakli G, Kurne A, Guven A, Serdaroglu A, Topaloglu H, Teber S, Anlar B (2009) Childhood optic neuritis: the pediatric neurologist\u2019s perspective. Eur J Paediatr Neurol 13:452\u2013457","journal-title":"Eur J Paediatr Neurol"},{"key":"7125_CR5","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1212\/01.wnl.0000344163.65326.48","volume":"72","author":"GR Bonhomme","year":"2009","unstructured":"Bonhomme GR, Waldman AT, Balcer LJ, Daniels AB, Tennekoon GI, Forman S, Galetta SL, Liu GT (2009) Pediatric optic neuritis: brain MRI abnormalities and risk of multiple sclerosis. Neurology 72:881\u2013885","journal-title":"Neurology"},{"key":"7125_CR6","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1177\/0883073808321052","volume":"24","author":"G Alper","year":"2009","unstructured":"Alper G, Wang L (2009) Demyelinating optic neuritis in children. J Child Neurol 24:45\u201348","journal-title":"J Child Neurol"},{"key":"7125_CR7","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1136\/adc.2009.175422","volume":"96","author":"M Absoud","year":"2011","unstructured":"Absoud M, Cummins C, Desai N, Gika A, McSweeney N, Munot P, Hemingway C, Lim M, Nischal KK, Wassmer E (2011) Childhood optic neuritis clinical features and outcome. Arch Dis Child 96:860\u2013862","journal-title":"Arch Dis Child"},{"key":"7125_CR8","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.jaapos.2011.05.020","volume":"15","author":"AT Waldman","year":"2011","unstructured":"Waldman AT, Stull LB, Galetta SL, Balcer LJ, Liu GT (2011) Pediatric optic neuritis and risk of multiple sclerosis: meta-analysis of observational studies. J AAPOS 15:441\u2013446","journal-title":"J AAPOS"},{"key":"7125_CR9","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.pediatrneurol.2015.05.010","volume":"53","author":"YM Kim","year":"2015","unstructured":"Kim YM, Kim HY, Cho MJ, Kwak MJ, Park KH, Yeon GM, Lee Y, Nam SO (2015) Optic neuritis in Korean children: low risk of subsequent multiple sclerosis. Pediatr Neurol 53:221\u2013225","journal-title":"Pediatr Neurol"},{"key":"7125_CR10","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.ophtha.2019.09.032","volume":"127","author":"JY Lee","year":"2020","unstructured":"Lee JY, Han J, Yang M, Oh SY (2020) Population-based incidence of pediatric and adult optic neuritis and the risk of multiple sclerosis. Ophthalmology 127:417\u2013425","journal-title":"Ophthalmology"},{"key":"7125_CR11","doi-asserted-by":"crossref","unstructured":"The clinical profile of optic neuritis (1991) Experience of the optic neuritis treatment trial\u00a0optic neuritis study group.\u00a0Optic Neuritis Study Group. Arch Ophthalmol 109(12):1673\u20131678","DOI":"10.1001\/archopht.1991.01080120057025"},{"key":"7125_CR12","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1038\/eye.2010.108","volume":"24","author":"JW Lee","year":"2010","unstructured":"Lee JW, Lai JS, Yick DW, Tse RK (2010) Retrospective case series on the long-term visual and intraocular pressure outcomes of phacomorphic glaucoma. Eye (Lond) 24:1675\u20131680","journal-title":"Eye (Lond)"},{"key":"7125_CR13","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1186\/s12974-018-1335-x","volume":"15","author":"HJ Lee","year":"2018","unstructured":"Lee HJ, Kim B, Waters P, Woodhall M, Irani S, Ahn S, Kim SJ, Kim SM (2018) Chronic relapsing inflammatory optic neuropathy (CRION): a manifestation of myelin oligodendrocyte glycoprotein antibodies. J Neuroinflammation 15:302","journal-title":"J Neuroinflammation"},{"issue":"3","key":"7125_CR14","doi-asserted-by":"publisher","first-page":"e708","DOI":"10.1212\/NXI.0000000000000708","volume":"7","author":"H Kim","year":"2020","unstructured":"Kim H, Lee EJ, Kim S, Choi LK, Kim K, Kim HW, Kim KK, Lim YM (2020) Serum biomarkers in myelin oligodendrocyte glycoprotein antibody-associated disease. Neurol Neuroimmunol Neuroinflamm 7(3):e708","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"7125_CR15","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","volume":"17","author":"AJ Thompson","year":"2018","unstructured":"Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, Correale J, Fazekas F, Filippi M, Freedman MS, Fujihara K, Galetta SL, Hartung HP, Kappos L, Lublin FD, Marrie RA, Miller AE, Miller DH, Montalban X et al (2018) Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol 17:162\u2013173","journal-title":"Lancet Neurol"},{"key":"7125_CR16","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","volume":"85","author":"DM Wingerchuk","year":"2015","unstructured":"Wingerchuk DM, Banwell B, Bennett JL, Cabre P, Carroll W, Chitnis T, de Seze J, Fujihara K, Greenberg B, Jacob A, Jarius S, Lana-Peixoto M, Levy M, Simon JH, Tenembaum S, Traboulsee AL, Waters P, Wellik KE, Weinshenker BG, International Panel for NMOD (2015) International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 85:177\u2013189","journal-title":"Neurology"},{"key":"7125_CR17","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1177\/1352458515593406","volume":"22","author":"S Ramanathan","year":"2016","unstructured":"Ramanathan S, Prelog K, Barnes EH, Tantsis EM, Reddel SW, Henderson AP, Vucic S, Gorman MP, Benson LA, Alper G, Riney CJ, Barnett M, Parratt JD, Hardy TA, Leventer RJ, Merheb V, Nosadini M, Fung VS, Brilot F, Dale RC (2016) Radiological differentiation of optic neuritis with myelin oligodendrocyte glycoprotein antibodies, aquaporin-4 antibodies, and multiple sclerosis. Mult Scler 22:470\u2013482","journal-title":"Mult Scler"},{"key":"7125_CR18","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.ejpn.2020.10.002","volume":"29","author":"M Baumann","year":"2020","unstructured":"Baumann M, Bartels F, Finke C, Adamsbaum C, Hacohen Y, Rostasy K, consortium EUpM (2020) E.U. paediatric MOG consortium consensus: Part 2 - Neuroimaging features of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders. Eur J Paediatr Neurol 29:14\u201321","journal-title":"Eur J Paediatr Neurol"},{"key":"7125_CR19","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1136\/jnnp-2014-310206","volume":"87","author":"T Akaishi","year":"2016","unstructured":"Akaishi T, Sato DK, Nakashima I, Takeshita T, Takahashi T, Doi H, Kurosawa K, Kaneko K, Kuroda H, Nishiyama S, Misu T, Nakazawa T, Fujihara K, Aoki M (2016) MRI and retinal abnormalities in isolated optic neuritis with myelin oligodendrocyte glycoprotein and aquaporin-4 antibodies: a comparative study. J Neurol Neurosurg Psychiatry 87:446\u2013448","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"7125_CR20","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1148\/rg.2018170141","volume":"38","author":"BG Dutra","year":"2018","unstructured":"Dutra BG, da Rocha AJ, Nunes RH, Maia ACM (2018) Neuromyelitis optica spectrum disorders: spectrum of MR imaging findings and their differential diagnosis. Radiographics 38:169\u2013193","journal-title":"Radiographics"},{"key":"7125_CR21","doi-asserted-by":"crossref","unstructured":"Paolilo RB, Hacohen Y, Yazbeck E, Armangue T, Bruijstens A, Lechner C, Apostolos-Pereira SL, Martynenko Y, Breu M, de Medeiros Rimkus C, Wassmer E, Baumann M, Papetti L, Capobianco M, Kornek B, Rost\u00e1sy K, da Paz JA, Ciccarelli O, Lim M, Saiz A, Neuteboom R, Marignier R, Hemingway C, Sato DK, Deiva K (2020) Treatment and outcome of aquaporin-4 antibody-positive NMOSD: A multinational pediatric study. Neurol Neuroimmunol Neuroinflamm 7(5):e837","DOI":"10.1212\/NXI.0000000000000837"},{"key":"7125_CR22","doi-asserted-by":"publisher","first-page":"540156","DOI":"10.3389\/fneur.2020.540156","volume":"11","author":"AG Filippatou","year":"2020","unstructured":"Filippatou AG, Mukharesh L, Saidha S, Calabresi PA, Sotirchos ES (2020) AQP4-IgG and MOG-IgG related optic neuritis-prevalence, optical coherence tomography findings, and visual outcomes: a systematic review and meta-analysis. Front Neurol 11:540156","journal-title":"Front Neurol"},{"key":"7125_CR23","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/S1474-4422(20)30432-4","volume":"20","author":"G Fadda","year":"2021","unstructured":"Fadda G, Armangue T, Hacohen Y, Chitnis T, Banwell B (2021) Paediatric multiple sclerosis and antibody-associated demyelination: clinical, imaging, and biological considerations for diagnosis and care. Lancet Neurol 20:136\u2013149","journal-title":"Lancet Neurol"},{"key":"7125_CR24","doi-asserted-by":"crossref","unstructured":"Cobo-Calvo A, Ruiz A, Rollot F, Arrambide G, Deschamps R, Maillart E, Papeix C, Audoin B, L\u00e9pine AF, Maurey H, Zephir H, Biotti D, Ciron J, Durand-Dubief F, Collongues N, Ayrignac X, Labauge P, Meyer P, Thouvenot E, Bourre B, Montcuquet A, Cohen M, Horello P, Tintor\u00e9 M, De Seze J, Vukusic S, Deiva K, Marignier R; NOMADMUS, KidBioSEP,\u00a0KidBioSEP, and OFSEP study groups\u00a0(2021) Clinical features and risk of relapse in children and adults with myelin oligodendrocyte glycoprotein antibody-associated disease. Ann Neurol 89(1):30\u201341","DOI":"10.1002\/ana.25909"},{"key":"7125_CR25","doi-asserted-by":"publisher","first-page":"e2142780","DOI":"10.1001\/jamanetworkopen.2021.42780","volume":"5","author":"C Satukijchai","year":"2022","unstructured":"Satukijchai C, Mariano R, Messina S, Sa M, Woodhall MR, Robertson NP, Ming L, Wassmer E, Kneen R, Huda S, Jacob A, Blain C, Halfpenny C, Hemingway C, O\u2019Sullivan E, Hobart J, Fisniku LK, Martin R, Dopson R et al (2022) Factors associated with relapse and treatment of myelin oligodendrocyte glycoprotein antibody-associated disease in the United Kingdom. JAMA Netw Open 5:e2142780","journal-title":"JAMA Netw Open"},{"key":"7125_CR26","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/s41582-018-0112-x","volume":"15","author":"M Reindl","year":"2019","unstructured":"Reindl M, Waters P (2019) Myelin oligodendrocyte glycoprotein antibodies in neurological disease. Nat Rev Neurol 15:89\u2013102","journal-title":"Nat Rev Neurol"},{"key":"7125_CR27","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1001\/jamaneurol.2018.1814","volume":"75","author":"AS Lopez-Chiriboga","year":"2018","unstructured":"Lopez-Chiriboga AS, Majed M, Fryer J, Dubey D, McKeon A, Flanagan EP, Jitprapaikulsan J, Kothapalli N, Tillema JM, Chen J, Weinshenker B, Wingerchuk D, Sagen J, Gadoth A, Lennon VA, Keegan BM, Lucchinetti C, Pittock SJ (2018) Association of MOG-IgG serostatus with relapse after acute disseminated encephalomyelitis and proposed diagnostic criteria for MOG-IgG-associated disorders. JAMA Neurol 75:1355\u20131363","journal-title":"JAMA Neurol"},{"key":"7125_CR28","doi-asserted-by":"publisher","first-page":"e055392","DOI":"10.1136\/bmjopen-2021-055392","volume":"11","author":"S Huda","year":"2021","unstructured":"Huda S, Whittam D, Jackson R, Karthikeayan V, Kelly P, Linaker S, Mutch K, Kneen R, Woodhall M, Murray K, Hunt D, Waters P, Jacob A (2021) Predictors of relapse in MOG antibody associated disease: a cohort study. BMJ Open 11:e055392","journal-title":"BMJ Open"},{"key":"7125_CR29","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/S1474-4422(19)30488-0","volume":"19","author":"T Armangue","year":"2020","unstructured":"Armangue T, Olive-Cirera G, Martinez-Hernandez E, Sepulveda M, Ruiz-Garcia R, Munoz-Batista M, Arino H, Gonzalez-Alvarez V, Felipe-Rucian A, Jesus Martinez-Gonzalez M, Cantarin-Extremera V, Concepcion Miranda-Herrero M, Monge-Galindo L, Tomas-Vila M, Miravet E, Malaga I, Arrambide G, Auger C, Tintore M et al (2020) Associations of paediatric demyelinating and encephalitic syndromes with myelin oligodendrocyte glycoprotein antibodies: a multicentre observational study. Lancet Neurol 19:234\u2013246","journal-title":"Lancet Neurol"},{"key":"7125_CR30","doi-asserted-by":"publisher","first-page":"103709","DOI":"10.1016\/j.msard.2022.103709","volume":"60","author":"Y Moon","year":"2022","unstructured":"Moon Y, Lim BC, Chae JH, Jung JH (2022) Clinical characteristics and clinical course of myelin oligodendrocyte glycoprotein antibody-seropositive pediatric optic neuritis. Mult Scler Relat Disord 60:103709","journal-title":"Mult Scler Relat Disord"},{"key":"7125_CR31","doi-asserted-by":"publisher","first-page":"3128","DOI":"10.1093\/brain\/awx276","volume":"140","author":"M Jurynczyk","year":"2017","unstructured":"Jurynczyk M, Messina S, Woodhall MR, Raza N, Everett R, Roca-Fernandez A, Tackley G, Hamid S, Sheard A, Reynolds G, Chandratre S, Hemingway C, Jacob A, Vincent A, Leite MI, Waters P, Palace J (2017) Clinical presentation and prognosis in MOG-antibody disease: a UK study. Brain 140:3128\u20133138","journal-title":"Brain"},{"key":"7125_CR32","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.ajo.2014.05.036","volume":"158","author":"MJ Wan","year":"2014","unstructured":"Wan MJ, Adebona O, Benson LA, Gorman MP, Heidary G (2014) Visual outcomes in pediatric optic neuritis. Am J Ophthalmol 158:503\u2013507 e502","journal-title":"Am J Ophthalmol"},{"key":"7125_CR33","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1097\/IIO.0b013e318259dec6","volume":"52","author":"MA El-Dairi","year":"2012","unstructured":"El-Dairi MA, Ghasia F, Bhatti MT (2012) Pediatric optic neuritis. Int Ophthalmol Clin 52:29\u201349 xii","journal-title":"Int Ophthalmol Clin"},{"key":"7125_CR34","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.jns.2011.03.038","volume":"306","author":"S Jarius","year":"2011","unstructured":"Jarius S, Paul F, Franciotta D, Ruprecht K, Ringelstein M, Bergamaschi R, Rommer P, Kleiter I, Stich O, Reuss R, Rauer S, Zettl UK, Wandinger KP, Melms A, Aktas O, Kristoferitsch W, Wildemann B (2011) Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: results from 211 lumbar punctures. J Neurol Sci 306:82\u201390","journal-title":"J Neurol Sci"},{"key":"7125_CR35","doi-asserted-by":"publisher","first-page":"726","DOI":"10.3389\/fimmu.2019.00726","volume":"10","author":"F Deisenhammer","year":"2019","unstructured":"Deisenhammer F, Zetterberg H, Fitzner B, Zettl UK (2019) The cerebrospinal fluid in multiple sclerosis. Front Immunol 10:726","journal-title":"Front Immunol"},{"key":"7125_CR36","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1186\/s12974-020-01824-2","volume":"17","author":"S Jarius","year":"2020","unstructured":"Jarius S, Pellkofer H, Siebert N, Korporal-Kuhnke M, Hummert MW, Ringelstein M, Rommer PS, Ayzenberg I, Ruprecht K, Klotz L, Asgari N, Zrzavy T, Hoftberger R, Tobia R, Buttmann M, Fechner K, Schanda K, Weber M, Asseyer S et al (2020) Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 1: Results from 163 lumbar punctures in 100 adult patients. J Neuroinflammation 17:261","journal-title":"J Neuroinflammation"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-023-07125-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-023-07125-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-023-07125-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T02:05:26Z","timestamp":1707530726000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-023-07125-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,19]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["7125"],"URL":"https:\/\/doi.org\/10.1007\/s10072-023-07125-9","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,19]]},"assertion":[{"value":"27 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the institutional review board of each participating facility and followed the tenets of the Declaration of Helsinki. The requirement for informed consent was waived due to the retrospective study design.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}